Episode 297: FIXED! 296. Is There a Drug That Will Keep Alcoholics Out of the Hospital?

Episode 297: FIXED! 296. Is There a Drug That Will Keep Alcoholics Out of the Hospital?

Bottom line

Do I think if you stop drinking alcohol in the next thirty days you are less likely to come to the hospital for a heart attack? A stroke? Pneumonia? copd exacerbations or CHF exacerbations?? The answer is no!! not in thirty days.. sure if you drag that out for months or years then yes you are at greater risk but for only 30 days of follow up realistically should be no difference in coming back to the hospital for things that are not alcohol related.

However there was still a significant improvement or decrease in alcohol related return to the hospital.

-- This is what most supporters will look at and say ‘see we should give this medication to everyone’

This get tricky because they lump together alcojol related ED visit and alcohol related readmission in their definition of alcohol related return to the hospital---- well hello!!!! You cant get readmitted if you don’t go to the ED so the real ‘return to the hospital’ is just alcohol return to the ED and by including alcohol relatated readmission with alcohol related ED visit you are just trying to artificially inflate your finding.

I know that they were just trying to artificially manipulate their finidings because as they say “””Alcohol-related ED visits did not reach statistical significance in relative terms (IRR, 0.61 [95% CI, “””

If your patient wants fda approved medications for alcohol use disorder then give it to them!! We shouldn’t without these medications but if you are giving it to them thinking it is some magical pill with a nnt of 4 to prevent death and the patient returning to the hospital then you will be sad!



https://pubmed.ncbi.nlm.nih.gov/38551564/



Episoder(385)

Episode 423: 430. Hormone Replacement Therapy and the Black Box Warning

Episode 423: 430. Hormone Replacement Therapy and the Black Box Warning

Let’s rewind to the early 2000s. Flip phones were cool, low-rise jeans were a crime, and the Women’s Health Initiative—WHI—dropped what became the medical equivalent of a headline: “Hormone Therapy In...

24 Mar 12min

Episode 422: 429. Rivaroxaban vs Apixaban = The Battle of the Blood Thinners!

Episode 422: 429. Rivaroxaban vs Apixaban = The Battle of the Blood Thinners!

— rivaroxaban versus apixaban.Yes, folks, this is The Battle of the Blood Thinners!And spoiler alert — one of them came out looking like the overachiever in a safety class... while the other probably ...

20 Mar 9min

Episode 421: 428. Asthma and Stroke --- A breathless combination

Episode 421: 428. Asthma and Stroke --- A breathless combination

Minocycline in Acute Ischemic Stroke (EMPHASIS trial)A multicenter, double-blind RCT in China studied 1,724 patients with acute ischemic stroke treated within 72 hours of onset. Patients received eith...

13 Mar 16min

Episode 420: 427. Kawasaki disease-no, not the motorcycle company

Episode 420: 427. Kawasaki disease-no, not the motorcycle company

Today, we're talking about Kawasaki disease-no, not the motorcycle company, though sometimes treating it does feel like trying to ride one at full speed through uncertainty.For decades, high-dose aspi...

11 Mar 7min

Episode 419: 426. Go Big or Go Partial? The Knee Replacement Showdown

Episode 419: 426. Go Big or Go Partial? The Knee Replacement Showdown

Setting the stagePicture this: your knee is like a three-room apartment. You've got a medial room, a lateral room, and a patellofemoral room. In isolated anteromedial osteoarthritis, just one room is ...

10 Mar 11min

Episode 418: 425. Triptan initiation and cerebrovascular events

Episode 418: 425. Triptan initiation and cerebrovascular events

Kalapura C, et al. Triptan initiation and cerebrovascular events in patients with migraine: A nationwide cohort study. J Am Heart Assoc 2026 Feb 17; 15:e043409. DOI: 10.1161/JAHA.125.043409.  Today, w...

6 Mar 6min

Episode 417: 424. GLP1 and NAION

Episode 417: 424. GLP1 and NAION

Li H-Y, et al. GLP-1 receptor agonists and risk of optic nerve or vision-threatening events in patients with type 2 diabetes or cardiometabolic diseases: A meta-analysis of randomized controlled trial...

5 Mar 8min

Episode 416: 423. CME-- Discharge Questions Answered in 2025

Episode 416: 423. CME-- Discharge Questions Answered in 2025

CME-- Discharge Questions Answered in 2025

3 Mar 45min

Populært innen Helse

fastlegen
lydartikler-fra-aftenposten
rss-gukild-johaug
hvordan-har-du-det-mann
psykodrama
leger-om-livet
rss-garne-damer
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
foreldreradet
rss-lopedrommen
morten-ramm-lar-kakla-ga-til-du-sovner
hjernesterk
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
klimaks
rss-lev-vel
sinnsyn
hormonelle-frida
g-punktet
rss-kunsten-a-leve
treningsprat